세계의 호르몬 대체요법 시장 : 요법 유형별, 투여 경로별, 용도별, 유통 채널별, 지역별

Hormone Replacement Therapy Market, By Therapy Type, By Route of Administration, By Application, By Distribution Channel, By Geography

US $ 4,500 ￦ 6,511,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,000 ￦ 10,128,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,469,000

PDF (Enterprise User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 호르몬 대체요법 시장 규모는 2025년 157억 8,000만 달러, 2032년에는 237억 5,000만 달러에 달할 것으로 예상되며, 2025-2032년 6.0%의 연평균 복합 성장률(CAGR)을 보일 전망입니다.

보고 범위		보고서 상세 내용
기준 연도	2024년	2025년 시장 규모	157억 8,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간(2025-2032년) CAGR	6.00%	2032년 가치 예측	237억 5,000만 달러

세계 호르몬 대체요법 시장은 전 세계 여성들의 폐경기 유병률이 증가함에 따라 지난 몇 년동안 큰 성장세를 보이고 있습니다. 호르몬 대체요법은 안면홍조, 식은땀, 질 건조증, 성욕감퇴, 기분 저하 등 폐경기 이후 경험하는 다양한 증상을 치료하는 데 도움이 됩니다. 호르몬 불균형과 노화로 인한 골다공증 및 기타 만성 질환에 대한 건강 문제가 증가하면서 효과적인 치료 솔루션에 대한 수요가 증가하고 있습니다. 또한, 여성 건강 문제에 대한 인식이 높아지고 다양한 호르몬 보충제 제제의 가용성이 예측 기간 동안 시장 확대를 촉진할 것으로 예상됩니다. 그러나 호르몬제의 장기 사용으로 인한 부작용과 대체 치료 옵션의 가용성 등의 요인은 시장 성장을 어느 정도 저해할 것으로 예상됩니다.

시장 역학:

세계 호르몬 대체요법 시장을 촉진하는 주요 요인으로는 호르몬 결핍에 취약한 노인 인구의 급증, 여성 갱년기 장애 발생률 증가, 전 세계 생활습관병의 급증, 만성질환 관리에서 호르몬 대체요법의 이점에 대한 인식 증가 등이 있습니다. 반면 유방암, 심장병, 뇌졸중, 혈전 등 호르몬제의 장기 사용에 따른 부작용은 시장 관계자들에게 큰 도전이 되고 있습니다. 그러나 새로운 약물 전달 시스템의 개발, 다양한 호르몬의 조합, 생동일성 호르몬 제제의 혁신을 위한 연구 개발의 진행은 향후 몇 년동안 이해관계자들에게 유리한 성장 기회를 제공할 것으로 예상됩니다.

본 조사의 주요 특징

• 세계의 호르몬 대체요법 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 CAGR(연평균 성장률)에 대해 조사 분석하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 고찰을 제공합니다.
• 세계 호르몬 대체요법 시장의 주요 기업 프로파일을 기업 개요, 제품 포트폴리오, 주요 특징, 실적, 전략 등의 파라미터를 기준으로 정리하여 수록하였습니다.
• 주요 기업으로는 Novartis AG, Abbott, Mylan NV, Merck KgaA, Bayer AG, Pfizer Inc. Amgen, Inc., Eli Lilly and Company, Halozyme Therapeutics, Inc.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 호르몬 대체 요법 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 호르몬 대체요법 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 주요 발전
• 규제 시나리오
• 제조업체 매출
• 비침습성 센서 기술 채택
• 인수와 제휴 시나리오
• 제품 발매/승인
• 자금조달과 투자
• PEST 분석
• Porter의 Five Forces 분석

제4장 세계의 호르몬 대체요법 시장 : COVID-19 팬데믹의 영향

• 전체적인 영향
• 정부 이니셔티브
• 시장에 대한 COVID-19의 영향

제5장 세계의 호르몬 대체요법 시장 : 요법 유형별(2020년-2032년)

• 에스트로겐 보충 요법
• 인간성장호르몬(HGH) 보충 요법
• 갑상선 보충 요법
• 테스토스테론 보충 요법
• 기타

제6장 세계의 호르몬 대체요법 시장 : 투여 경로별(2020년-2032년)

• 경구
• 비경구
• 기타

제7장 세계의 호르몬 대체요법 시장 : 용도별(2020년-2032년)

• 갑상선 기능 저하증
• 남성 성선 기능 저하증
• 성장호르몬 결핍증
• 기타

제8장 세계의 호르몬 대체요법 시장 : 유통 채널별(2020년-2032년)

• 원내 약국
• 소매 약국
• 온라인 약국

제9장 세계의 호르몬 대체요법 시장 : 지역별(2020년-2032년)

• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제10장 경쟁 구도

• 기업 개요
  • Novartis AG
  • Abbott
  • Mylan NV
  • Merck KgaA
  • Bayer AG
  • Pfizer Inc.
  • Novo Nordisk A/S
  • QuatRx Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Amgen, Inc.
  • Eli Lilly and Company
  • Halozyme Therapeutics, Inc.
  • AbbVie, Inc.
  • Noven Pharmaceuticals, Inc.
  • I-MAB Biopharma Co., Ltd.
  • Myovant Sciences

제11장 애널리스트의 견해

• Wheel of Fortune
• 애널리스트의 견해
• Coherent Opportunity Map(COM)

제12장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

LSH

영문 목차

영문목차

Global Hormone Replacement Therapy Market is estimated to be valued at USD 15.78 Bn in 2025 and is expected to reach USD 23.75 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.0% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 15.78 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.00%	2032 Value Projection:	USD 23.75 Bn

The global hormone replacement therapy market has been witnessing significant growth over the past few years owing to the rising prevalence of menopause among women worldwide. Hormone replacement therapy helps treat various symptoms experienced during and after menopause like hot flashes, night sweats, vaginal dryness, low libido, and mood swings. Growing health concerns pertaining to osteoporosis and other chronic diseases due to hormonal imbalance and aging are driving the demand for effective therapeutic solutions. Furthermore, increasing awareness about women's health issues and availability of various hormone replacement drug formulations are expected to propel the market expansion during the forecast period. However, factors like side effects associated with long-term usage of hormones and availability of alternative treatment options continue to impede the market growth to a certain extent.

Market Dynamics:

The key drivers fueling the global hormone replacement therapy market include rapidly growing geriatric population susceptible to hormonal deficiencies, rising incidence of menopause among women, upsurge in lifestyle diseases globally, and increasing awareness about benefits of hormone replacement therapy in chronic disease management. On the other hand, side effects pertaining to long-term usage of hormones including Breast cancer, heart disease, stroke, and blood clots pose major challenges for market players. However, ongoing R&D towards development of novel drug delivery systems, combining various hormones, and innovation in bioidentical hormone formulations are expected to unlock lucrative growth opportunities for stakeholders in coming years.

Key Features of the Study:

• This report provides an in-depth analysis of the global hormone replacement therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global hormone replacement therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this includes Novartis AG, Abbott , Mylan NV, Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., Eli Lilly and Company, Halozyme Therapeutics, Inc., AbbVie, Inc., Noven Pharmaceuticals, Inc., I-MAB Biopharma Co., Ltd., and Myovant Sciences
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global hormone replacement therapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hormone replacement therapy market

Detailed Segmentation-

• By Therapy Type:
  • Estrogen Replacement Therapy
  • Human Growth Hormone (HGH) Replacement Therapy
  • Thyroid Replacement Therapy
  • Testosterone Replacement Therapy
  • Others
• By Route of Administration:
  • Oral
  • Parenteral
  • Others
• By Application:
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Novartis AG
  • Abbott
  • Mylan NV
  • Merck KgaA
  • Bayer AG
  • Pfizer Inc.
  • Novo Nordisk A/S
  • QuatRx Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Amgen, Inc.
  • Eli Lilly and Company
  • Halozyme Therapeutics, Inc.
  • AbbVie, Inc.
  • Noven Pharmaceuticals, Inc.
  • I-MAB Biopharma Co., Ltd.
  • Myovant Sciences

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Therapy Type
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Application
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Manufacturer Revenue
• Adoption of Non-invasive Sensor Technologies
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Hormone Replacement Therapy Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Hormone Replacement Therapy Market, By Therapy Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Estrogen Replacement Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Human Growth Hormone (HGH) Replacement Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Thyroid Replacement Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Testosterone Replacement Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Hormone Replacement Therapy Market, By Route of Administration, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Parenteral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Hormone Replacement Therapy Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hypothyroidism
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Male Hypogonadism
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Growth Hormone Deficiency
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Hormone Replacement Therapy Market, By Distribution Channel, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Hormone Replacement Therapy Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profiles
  • Novartis AG*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott
  • Mylan NV
  • Merck KgaA
  • Bayer AG
  • Pfizer Inc.
  • Novo Nordisk A/S
  • QuatRx Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Amgen, Inc.
  • Eli Lilly and Company
  • Halozyme Therapeutics, Inc.
  • AbbVie, Inc.
  • Noven Pharmaceuticals, Inc.
  • I-MAB Biopharma Co., Ltd.
  • Myovant Sciences

11. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

관련자료